Parkinson's Blog

Teaching exercise to people with Parkinson’s disease has enriched the author’s life both professionally and personally.

New Delhi, Feb 29 (PTI) Researchers from the Indian Institute of Technology (IIT) Mandi and three US universities have investigated a crucial protein involved in the progression of Parkinson’s disease. According to officials, Parkinson’s disease is on the rise globally, with experts projecting a substantial 200-300 per cent increase in cases in India over the […]

In a groundbreaking study, the Indian Institute of Technology Mandi has collaborated with international researchers to uncover critical insights into the treatment of Parkinson’s disease. The focus of the research was on Alpha-synuclein, a brain-abundant protein that undergoes increased phosphorylation in Parkinson’s patients. Parkinson’s disease, a neurodegenerative disorder, has seen a rising prevalence globally, with […]

Amneal has signed an agreement with Zambon Biotech for IPX203 for the treatment of Parkinson’s disease (PD) in certain regions.

Discover how a community-led VR trial in the North-East is transforming the treatment landscape for Parkinson’s patients. Explore the innovative approach and promising outcomes of this groundbreak…

As well as a Phase IIb trial of pirepemat, IRLAB is also looking to launch a Phase III trial of its candidate mesdopetam.

Discover the latest research findings on the intricate relationship between aging, Parkinson’s disease, and dopaminergic neurons. Uncover key markers distinguishing healthy and aged cells, sheddin…

Recent research on Parkinson’s disease patients has uncovered a new neurochemical mechanism underlying human decision-making processes based on social context. The study sheds light on the role of…

Enjoy organ performances from members of the American Guild of Organists (St. Louis chapter) and raise money for the American Parkinson’s Disease Association on Monday, March 18, 7:30 p.m. at

Discover how Tanzania, in partnership with the WHO, is revolutionizing access to medication for epilepsy and Parkinson’s disease, offering hope to hundreds of thousands of Tanzanians.